Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2009;11(5):125.
doi: 10.1186/ar2786. Epub 2009 Sep 14.

Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems

Guido Valesini, Cristiano Alessandri
Editorial

Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems

Guido Valesini et al. Arthritis Res Ther. 2009.

Abstract

In a previous issue of Arthritis Research and Therapy, Ursum and colleagues report the relative stabilities of anticitrullinated protein/peptide antibodies (ACPAs) and IgM rheumatoid factors during the course of rheumatoid arthritis and their differential correlation with markers of the acute-phase response. These findings add to a growing body of evidence highlighting the distinct nature of these two autoantibody systems and the role of ACPAs as a disease-specific marker of rheumatoid arthritis.

PubMed Disclaimer

Comment on

References

    1. Ursum J, Bos WH, Stadt RJ van de, Dijkmans BAC, van Schaardenburg D. Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoanti-body systems. A cohort study. Arthritis Res Ther. 2009;11:R75. doi: 10.1186/ar2704. - DOI - PMC - PubMed
    1. Rönnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis. 2005;64:1744–1749. doi: 10.1136/ard.2004.033571. - DOI - PMC - PubMed
    1. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S. Meta-analysis: diagnostic accuracy of anticyclicncitrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146:797–808. - PubMed
    1. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2006;65:845–851. doi: 10.1136/ard.2006.051391. - DOI - PMC - PubMed
    1. Vossenaar ER, Després N, Lapointe E, Heijden A van der, Lora M, Senshu T, van Venrooij WJ, Ménard HA. RA specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther. 2004;6:R142–R150. doi: 10.1186/ar1149. - DOI - PMC - PubMed